Niki BioSolutions, Inc.: 20-F filed 2025-04-30

Name: Niki BioSolutions, Inc.: 20-F filed 2025-04-30
Creator: Niki BioSolutions, Inc.

What Niki BioSolutions, Inc. reported in its annual report (foreign private issuer) filed 2025-04-30 (fiscal FY 2024): 43 published measures, 99 facts as tagged in accession 0001213900-25-037669.

This filing

Form: 20-F (annual report (foreign private issuer))
Filed: 2025-04-30
Fiscal period: fiscal FY 2024
Accession: 0001213900-25-037669 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Niki BioSolutions, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2024-12-31	16,130,223	USD
At 2023-12-31	20,640,091	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2024-12-31	4,353,162	USD
At 2023-12-31	5,256,738	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2024-12-31	21,134,514	USD
At 2023-12-31	24,846,236	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	-4,267,806	USD	366
2023-01-01 to 2023-12-31	-2,824,647	USD	365
2022-01-01 to 2022-12-31	-9,799,560	USD	365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	-1,189,734	USD	366
2023-01-01 to 2023-12-31	-7,724,364	USD	365
2022-01-01 to 2022-12-31	-12,318,965	USD	365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2023-01-01 to 2023-12-31	3,015	USD	365
2022-01-01 to 2022-12-31	186,916	USD	365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2023-01-01 to 2023-12-31	431,378	USD	365
2022-01-01 to 2022-12-31	1,295,889	USD	365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2023-01-01 to 2023-12-31	4,092,068	USD	365
2022-01-01 to 2022-12-31	6,625,462	USD	365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	58,621	USD	366
2023-01-01 to 2023-12-31	624,767	USD	365
2022-01-01 to 2022-12-31	2,444,896	USD	365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2024-12-31	-72,429,528	USD
At 2023-12-31	-68,161,722	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	5,453,103	shares	366
2023-01-01 to 2023-12-31	4,521,133	shares	365
2022-01-01 to 2022-12-31	3,569,484	shares	365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	5,453,103	shares	366
2023-01-01 to 2023-12-31	4,521,133	shares	365
2022-01-01 to 2022-12-31	3,569,484	shares	365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	-0.78	USD/shares	366
2023-01-01 to 2023-12-31	-0.62	USD/shares	365
2022-01-01 to 2022-12-31	-2.75	USD/shares	365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	-0.78	USD/shares	366
2023-01-01 to 2023-12-31	-0.62	USD/shares	365
2022-01-01 to 2022-12-31	-2.75	USD/shares	365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2023-12-31	1,663,926	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2023-01-01 to 2023-12-31	1,265,189	USD	365
2022-01-01 to 2022-12-31	1,646,999	USD	365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2024-12-31	959,554	USD
At 2023-12-31	2,476,092	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2024-12-31	4,338,980	USD
At 2023-12-31	2,098,753	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2023-12-31	47,709	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2023-01-01 to 2023-12-31	31,030	USD	365

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2023-01-01 to 2023-12-31	420,812	USD	365
2022-01-01 to 2022-12-31	1,215,824	USD	365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	2,195,161	USD	366
2023-01-01 to 2023-12-31	5,198,329	USD	365
2022-01-01 to 2022-12-31	9,219,595	USD	365

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

Period	Value	Unit
At 2024-12-31	874,238	USD
At 2023-12-31	2,005,351	USD
At 2022-12-31	5,012,880	USD
At 2021-12-31	8,261,487	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2024-12-31	89,162	USD
At 2023-12-31	-10,623	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit
At 2024-12-31	11,777,061	USD
At 2023-12-31	15,383,353	USD
At 2022-12-31	7,833,305	USD
At 2021-12-31	17,506,122	USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit	Days
At 2023-12-31	182,057	USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

Period	Value	Unit	Days
At 2024-12-31	116,407	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2024-12-31	4,784,728	USD
At 2023-12-31	5,351,262	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2024-12-31	4,784,728	USD
At 2023-12-31	3,687,336	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2023-12-31	147,347	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2024-12-31	85,316	USD
At 2023-12-31	422,071	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	-4,157,737	USD	366
2023-01-01 to 2023-12-31	-4,340,975	USD	365
2022-01-01 to 2022-12-31	-11,525,102	USD	365

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	-4,057,952	USD	366
2023-01-01 to 2023-12-31	-4,385,405	USD	365
2022-01-01 to 2022-12-31	-11,489,276	USD	365

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	-4,267,806	USD	366
2023-01-01 to 2023-12-31	-2,824,647	USD	365
2022-01-01 to 2022-12-31	-9,799,560	USD	365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	669,486	USD	366
2023-01-01 to 2023-12-31	1,930,637	USD	365
2022-01-01 to 2022-12-31	5,220,405	USD	365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	235,827	USD	366
2023-01-01 to 2023-12-31	1,041,234	USD	365
2022-01-01 to 2022-12-31	1,092,957	USD	365

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	19,219	USD	366
2023-01-01 to 2023-12-31	84,020	USD	365
2022-01-01 to 2022-12-31	114,553	USD	365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	-217,196	USD	366
2023-01-01 to 2023-12-31	6,383,276	USD	365
2022-01-01 to 2022-12-31	5,984,011	USD	365

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2023-01-01 to 2023-12-31	94,108	USD	365
2022-01-01 to 2022-12-31	64,744	USD	365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2023-01-01 to 2023-12-31	1,575,562	USD	365

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	120,824	USD	366
2023-01-01 to 2023-12-31	389,365	USD	365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2024-01-01 to 2024-12-31	-41,349	USD	366
2023-01-01 to 2023-12-31	-126,717	USD	365
2022-01-01 to 2022-12-31	95,704	USD	365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2023-01-01 to 2023-12-31	-14,516	USD	365
2022-01-01 to 2022-12-31	-8,053	USD	365

Inspect the source

Entity: Niki BioSolutions, Inc. / CIK 0001734005
Captured: 2026-09-21T17:25:26.957Z
SEC response SHA-256: f34238bceb73cca1adaefab8f58fd2e934415f294cf76da9d5479015a6447310

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001734005.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))